These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19080990)

  • 41. Childhood generalized pustular psoriasis: longtime remission with combined infliximab and methotrexate treatment.
    Skrabl-Baumgartner A; Weger W; Salmhofer W; Jahnel J
    Pediatr Dermatol; 2015; 32(1):e13-4. PubMed ID: 25644044
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Two cases of atopic dermatitis-like conditions induced in psoriasis patients treated with infliximab.
    Vestergaard C; Deleuran M; Kragballe K
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1272-4. PubMed ID: 17894730
    [No Abstract]   [Full Text] [Related]  

  • 43. [Patient education. Information letter on treatment of psoriasis with infliximab (Remicade)].
    Groupe de recherche sur psoriasis de Société française de dermatologie, mai 2011
    Ann Dermatol Venereol; 2011 Dec; 138(12):865-7. PubMed ID: 22137633
    [No Abstract]   [Full Text] [Related]  

  • 44. Infliximab then efalizumab, the 'hit and run' approach does not work.
    Barde C; Thielen AM; Saurat JH
    Dermatology; 2008; 216(2):171-2. PubMed ID: 18216482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort.
    Dalaker M; Bonesrønning JH
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):277-82. PubMed ID: 19207642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Persistent expression of CD26/DPPIV after treatment with infliximab in psoriasis despite clinical improvement.
    van Lingen RG; van Erp PE; Seyger MM; de Jong EM; de Boer-van Huizen RT; Driessen RJ; van de Kerkhof PC
    Acta Derm Venereol; 2009; 89(5):518-20. PubMed ID: 19734982
    [No Abstract]   [Full Text] [Related]  

  • 47. Gastric MALT lymphoma in a patient receiving infliximab for psoriasis.
    Girard C; Guillot B; Bessis D
    Br J Dermatol; 2008 Aug; 159(2):497-8. PubMed ID: 18547313
    [No Abstract]   [Full Text] [Related]  

  • 48. Guselkumab (Tremfya) for psoriasis.
    Med Lett Drugs Ther; 2017 Nov; 59(1533):179-180. PubMed ID: 29125591
    [No Abstract]   [Full Text] [Related]  

  • 49. Fatal fulminant legionnaires' disease in a patient with severe erythodermic psoriasis treated with infliximab after long-term steroid therapy.
    Eisendle K; Fritsch P
    Br J Dermatol; 2005 Mar; 152(3):585-6. PubMed ID: 15787843
    [No Abstract]   [Full Text] [Related]  

  • 50. Alopecia areata during treatment with biologic agents.
    Tosti A; Pazzaglia M; Starace M; Bellavista S; Vincenzi C; Tonelli G
    Arch Dermatol; 2006 Dec; 142(12):1653-4. PubMed ID: 17179002
    [No Abstract]   [Full Text] [Related]  

  • 51. Urticarial vasculitis due do infliximab.
    Goulão J; Cunha H; Anes I; Bártolo E; Furtado C; Serrano P; Brandão FM
    J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):882-3. PubMed ID: 18462298
    [No Abstract]   [Full Text] [Related]  

  • 52. Striking and rapid improvement of plaque psoriasis with infliximab. A report of two cases.
    Al-Salem IH
    Dermatology; 2003; 207(1):54-6. PubMed ID: 12835550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autoimmune hepatitis associated with infliximab in a patient with palmoplantar pustular psoriaisis.
    Fairhurst DA; Sheehan-Dare R
    Clin Exp Dermatol; 2009 Apr; 34(3):421-2. PubMed ID: 19309375
    [No Abstract]   [Full Text] [Related]  

  • 54. Broadalumab (Siliq)--another IL-17A antagonist for psoriasis.
    Med Lett Drugs Ther; 2017 Jul; 59(1525):118-119. PubMed ID: 28699932
    [No Abstract]   [Full Text] [Related]  

  • 55. Infliximab associated new-onset psoriasis.
    Adams DR; Buckel T; Sceppa JA
    J Drugs Dermatol; 2006 Feb; 5(2):178-9. PubMed ID: 16485887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Infliximab rescue of efalizumab withdrawal flare and psoriasis-precipitated depression.
    Yip L; Harrison S; Foley P
    Australas J Dermatol; 2008 Nov; 49(4):250-1. PubMed ID: 18855796
    [No Abstract]   [Full Text] [Related]  

  • 57. [Infliximab].
    Goujon C; Bachelez H
    Ann Dermatol Venereol; 2011 Dec; 138(12):839-41. PubMed ID: 22137623
    [No Abstract]   [Full Text] [Related]  

  • 58. Acute treatment of generalized pustular psoriasis of von Zumbusch with single-dose infliximab.
    Smith N; Harms KL; Hines AC; Harms PW; Gudjonsson JE; Hristov AC; Wang F
    J Am Acad Dermatol; 2013 Jun; 68(6):e187-9. PubMed ID: 23680215
    [No Abstract]   [Full Text] [Related]  

  • 59. Tildrakizumab (Ilumya) - another IL-23 antagonist for psoriasis.
    Med Lett Drugs Ther; 2019 Jan; 60(1563):4-6. PubMed ID: 30681661
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of inverse psoriasis with efalizumab.
    George D; Rosen T
    J Drugs Dermatol; 2009 Jan; 8(1):74-6. PubMed ID: 19180901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.